PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11190.51 Billion IDR | 17.57% |
| 2022 | 9518.01 Billion IDR | 1.45% |
| 2021 | 9381.89 Billion IDR | 31.95% |
| 2020 | 7110.12 Billion IDR | 1.31% |
| 2019 | 7017.91 Billion IDR | 17.66% |
| 2018 | 5964.65 Billion IDR | 1.99% |
| 2017 | 5848 Billion IDR | 13.15% |
| 2016 | 5168.36 Billion IDR | 24.72% |
| 2015 | 4144.11 Billion IDR | 24.05% |
| 2014 | 3340.79 Billion IDR | 33.44% |
| 2013 | 2503.59 Billion IDR | 40.02% |
| 2012 | 1788.08 Billion IDR | 41.98% |
| 2011 | 1259.34 Billion IDR | 22.21% |
| 2010 | 1030.47 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 3106.59 Billion IDR | 3.91% |
| 2024 Q2 | 2989.56 Billion IDR | -1.24% |
| 2024 Q1 | 3027.02 Billion IDR | 2.79% |
| 2023 Q3 | 2963.61 Billion IDR | 12.78% |
| 2023 Q2 | 2627.76 Billion IDR | -1.0% |
| 2023 Q1 | 2654.22 Billion IDR | 2.62% |
| 2023 FY | 11190.51 Billion IDR | 17.57% |
| 2023 Q4 | 2944.91 Billion IDR | -0.63% |
| 2022 FY | 9518.01 Billion IDR | 1.45% |
| 2022 Q4 | 2586.52 Billion IDR | 2.58% |
| 2022 Q3 | 2521.55 Billion IDR | 15.24% |
| 2022 Q2 | 2188.12 Billion IDR | -1.52% |
| 2022 Q1 | 2221.81 Billion IDR | -0.74% |
| 2021 Q4 | 2238.38 Billion IDR | -32.82% |
| 2021 Q2 | 1899.38 Billion IDR | -0.67% |
| 2021 Q3 | 3331.99 Billion IDR | 75.42% |
| 2021 FY | 9381.89 Billion IDR | 31.95% |
| 2021 Q1 | 1912.11 Billion IDR | -9.33% |
| 2020 FY | 7110.12 Billion IDR | 1.31% |
| 2020 Q2 | 1299.43 Billion IDR | -30.75% |
| 2020 Q1 | 1876.31 Billion IDR | 4.11% |
| 2020 Q4 | 2108.82 Billion IDR | 15.52% |
| 2020 Q3 | 1825.55 Billion IDR | 40.49% |
| 2019 FY | 7017.91 Billion IDR | 17.66% |
| 2019 Q3 | 1838.84 Billion IDR | 10.38% |
| 2019 Q2 | 1665.98 Billion IDR | -2.62% |
| 2019 Q4 | 1802.22 Billion IDR | -1.99% |
| 2019 Q1 | 1710.86 Billion IDR | 9.07% |
| 2018 Q3 | 1547.52 Billion IDR | 10.44% |
| 2018 Q4 | 1568.65 Billion IDR | 1.37% |
| 2018 FY | 5964.65 Billion IDR | 1.99% |
| 2018 Q1 | 1447.19 Billion IDR | -6.99% |
| 2018 Q2 | 1401.27 Billion IDR | -3.17% |
| 2017 FY | 5848 Billion IDR | 13.15% |
| 2017 Q3 | 1534.19 Billion IDR | 13.98% |
| 2017 Q1 | 1411.85 Billion IDR | 5.05% |
| 2017 Q4 | 1555.91 Billion IDR | 1.42% |
| 2017 Q2 | 1346.03 Billion IDR | -4.66% |
| 2016 Q3 | 1269.55 Billion IDR | -2.42% |
| 2016 FY | 5168.36 Billion IDR | 24.72% |
| 2016 Q2 | 1300.98 Billion IDR | 3.76% |
| 2016 Q1 | 1253.83 Billion IDR | 10.86% |
| 2016 Q4 | 1343.99 Billion IDR | 5.86% |
| 2015 Q1 | 976.38 Billion IDR | 5.5% |
| 2015 Q2 | 1010.57 Billion IDR | 3.5% |
| 2015 FY | 4144.11 Billion IDR | 24.05% |
| 2015 Q4 | 1130.97 Billion IDR | 10.21% |
| 2015 Q3 | 1026.18 Billion IDR | 1.54% |
| 2014 Q3 | 847.43 Billion IDR | 3.78% |
| 2014 Q2 | 816.61 Billion IDR | 8.7% |
| 2014 Q1 | 751.24 Billion IDR | 11.5% |
| 2014 FY | 3340.79 Billion IDR | 33.44% |
| 2014 Q4 | 925.5 Billion IDR | 9.21% |
| 2013 Q4 | 673.78 Billion IDR | 7.21% |
| 2013 Q1 | 584.02 Billion IDR | 11.28% |
| 2013 FY | 2503.59 Billion IDR | 40.02% |
| 2013 Q2 | 617.31 Billion IDR | 5.7% |
| 2013 Q3 | 628.47 Billion IDR | 1.81% |
| 2012 Q4 | 524.84 Billion IDR | 0.0% |
| 2012 FY | 1788.08 Billion IDR | 41.98% |
| 2011 FY | 1259.34 Billion IDR | 22.21% |
| 2010 FY | 1030.47 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Bundamedik Tbk | 1488.19 Billion IDR | -651.951% |
| PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -4511.206% |
| PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | -93.471% |
| PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | -162.424% |
| PT Murni Sadar Tbk | 921.91 Billion IDR | -1113.835% |
| PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | -508.434% |
| PT Royal Prima Tbk | 265.33 Billion IDR | -4117.472% |
| PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -2896.924% |
| PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | -628.72% |
| PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | -347.053% |